secwatch.observer — SEC 8-K summary
======================================

Issuer:     Inspire Medical Systems, Inc. (INSP)
CIK:        0001609550
Form:       8-K
Filed at:   2022-06-22T23:59:59+00:00
Accession:  0001609550-22-000030
Event type: debt
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Inspire Medical amends loan agreement to set German subsidiary asset and income limits
--------------------------------------------------------------------------------

- German subsidiary GMBH exempted from subsidiary joinder requirements in loan agreement.
- GMBH cannot hold IP; cash limited to $7M and annual net income over €2M must be transferred to parent.
- Permitted foreign bank account aggregate limit raised to $10M from prior $10M (no change?) – actually increased from previous unspecified lower limit.
- Quarterly investment cap of $5M in GMBH added as Permitted Investment.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1609550/000160955022000030/0001609550-22-000030-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1609550/000160955022000030/insp-20220615.htm
  HTML page:      https://secwatch.observer/filing/0001609550-22-000030

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer